Sunday 19 November 2017
Contact US    |    Archive
PR
2 months ago

Vanda s Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis

WASHINGTON, Sept. 13, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today a

Read on the original site


Hashtags:   

Vanda

 | 

Tradipitant

 | 

Improves

 | 

Itch

 | 

and

 | 

Disease

 | 

Severity

 | 

Patients

 | 

with

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries